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Abstract
Background: The objective of this article is to describe the design of an evaluation of the cost-effectiveness of
systematic home visits by nurses to frail elderly primary care patients. Pilot objectives were: 1. To determine the
feasibility of postal multidimensional frailty screening instruments; 2. to identify the need for home visits to elderly.
Methods: Main study: The main study concerns a randomized controlled in primary care practices (PCP) with 18
months follow-up and blinded PCPs. Frail persons aged 75 years or older and living at home but neither terminally
ill nor demented from 33 PCPs were eligible. Trained community nurses (1) visit patients at home and assess the
care needs with the Resident Assessment Instrument-Home Care, a multidimensional computerized geriatric
assessment instrument, enabling direct identification of problem areas; (2) determine the care priorities together
with the patient; (3) design and execute interventions according to protocols; (4) and visit patients at least five
times during a year in order to execute and monitor the care-plan. Controls receive usual care. Outcome
measures are Quality of life, and Quality Adjusted Life Years; time to nursing home admission; mortality; hospital
admissions; health care utilization.
Pilot 1: Three brief postal multidimensional screening measures to identify frail health among elderly persons were
tested on percentage complete item response (selected after a literature search): 1) Vulnerable Elders Screen, 2)
Strawbridge's frailty screen, and 3) COOP-WONCA charts.
Pilot 2: Three nurses visited elderly frail patients as identified by PCPs in a health center of 5400 patients and used
an assessment protocol to identify psychosocial and medical problems. The needs and experiences of all
participants were gathered by semi-structured interviews.
Discussion: The design holds several unique elements such as early identification of frail persons combined with
case-management by nurses.
From two pilots we learned that of three potential postal frailty measures, the COOP-WONCA charts were 
completed best by elderly and that preventive home visits by nurses were positively evaluated to have potential 
for quality of care improvement.
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Publishing the design of a study
Publishing the design and protocol of a study before
results are available is important for several reasons. A
published protocol allows easier comparison between
what was originally intended and hypothesized and what
was actually done, and it gives readers greater insight into
the methodological quality of a study [1]. Furthermore, it
has often been recognized that negative or adverse out-
comes are less likely to be published [2]. Publishing the
design of a study before its start announces the study will
be undertaken, which encourages publication of the
results and in any case informs researchers where they can
find the data for inclusion in systematic reviews [1,1,2].
Thus, publishing a design article can prevent publication
bias. In addition, publishing pilot results provides a better
insight in the choices for particular instruments and
interventions.
Primary care and elderly
In the Netherlands all people are registered in a primary
care practice and Primary Care Physicians (PCPs) act as
gatekeepers to specialist care, whereas for example in the
USA most persons are not registered in a primary care
practice [3]. There are few barriers to primary care facilities
in the Netherlands and in the Netherlands about 86% of
older people contact their PCP yearly [4]. Older persons in
primary care are, therefore, a good representation of the
total older population at risk. Primary care is confronted
with increasing numbers of frail elderly because of the
aging of the population, and their wish to live independ-
ently for as long as possible. Frailty poses a complex prob-
lem for primary care. Up to about 20% of the elderly,
defined here as those 75 years of age and over are vulner-
able for further deterioration of functional abilities and
quality of life accompanied by a substantial increased risk
of institutionalization [5]. This implies an exploding need
for care.
Primary care is insufficiently equipped for a potential
explosion of care needs. GPs are often unaware of the
health status and functional limitations of their elderly
patients [6,7]. Several studies reported a considerable
amount of undetected morbidity both among consulting
and non-consulting patients [8,9]. Moreover, PCPs, as the
medically responsible person, do not regard themselves
suited for systematic management and long-term moni-
toring for chronic diseases and disabilities associated with
frail health [10].
Proactive detection of care needs in elderly but still com-
petent persons who do not explicitly seek help is at odds
with the prevailing reactive paradigm in primary care.
However, as perhaps many frail elderly are unaware of the
types of help available, there is a need for care experi-
ments with transmural collaboration among health pro-
fessionals, which might increase the quality of (primary)
care for frail persons at home.
Earlier interventions
Systematic home visits to frail elderly by nurses can reduce
mortality and nursing home admissions provided that a
substantial number of home visits are paid and care plans
are based on multidimensional assessments [11,12]. In
addition, accumulating evidence shows that preventive
home visits are mostly accompanied by a reduction of
health care costs [13]. Both from patient (health gains)
and societal (cost savings) perspective this is a desirable
situation.
Frailty and preventive mechanisms
Frailty is the result of reduced ability to maintain a physi-
ological and psychosocial equilibrium, thereby increasing
the risk of functional disability, temporary or permanent
loss of the ability to cope, morbidity, and mortality [14-
16]. Frailty is strongly associated with aging [17,18]. The
potential preventive mechanisms of home visits comprise
early detection of worsening health conditions and mod-
ifiable risk factors, enabling concerted actions with
responsible health professionals to optimize treatment,
improve life style and increase support for family caregiv-
ers to persevere informal care.
Costs
Aging is costly. About one third of the health care expen-
ditures in industrialized countries relate to persons 70
years or older [19]. Nursing homes, homes for the elderly
and hospital beds are occupied mainly by elderly. Elderly
are massive consumers of medication. Elderly consume
most home care. When the number and portion of (frail)
elderly increases the health care costs will explode. Among
community dwelling elderly with usual care the median
annual nursing home and hospital admission rate is 2.4%
(range 0–40%) respectively 26% (range 5–56%). Among
frail elderly median annual admission rates are 15% and
45% respectively [11,12].
Objectives
To describe the design of an evaluation of the cost-effec-
tiveness of systematic home visits by nurses to frail elderly
primary care patients. Pilot objectives were to determine
the feasibility of postal multidimensional frailty screening
instruments and to identify the need for home visits to
frail elderly. This article describes the background, design
and pilot results.Page 2 of 9
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Pilot 1: Selecting frail patients by postal questionnaires 
(Table 2)
After a literature search three multidimensional screening
instruments were selected and tested in one primary care
practice among all 118 75+ patients: 1) VES-13, 2) Straw-
bridge's frailty screen, and 3) COOP-WONCA charts [20-
22]. Feasibility was expressed in percentage complete item
response. Our goal was to identify the worst quarter.
Pilot 2: Exploring the potential for quality of care 
improvement of preventive home visits among elderly 
persons (Table 3)
The setting was a health center of 5400 patients with 3
PCPs and a practice nurse. Possible frailty was determined
by the PCPs among their 75+ patients in the following
cases: beginning dementia, active carcinoma, two or more
medications for organ indication, treatments by two or
more medical specialists, being 85+ and not contacted the
PCP over the last three years, uncertainty regarding the
ability to manage oneself, and all other persons the PCP
felt it necessary to pay attention to. The nurses visited the
patients and used an elaborate geriatric assessment proto-
col to identify psychosocial and medical problems. The
nurses and the PCPs designed a care plan. The experiences
of all participants were gathered by semi-structured
interviews.
Main study
Design
A randomized controlled trial in 33 primary care practices
(55 primary care physicians) among frail 75+ patients at
home who responded to a Health Screener, with 18
months follow-up. Frail persons living at the same address
were randomized as one unit. PCPs are held blind for the
group assignment. Block-randomization ensured equal
numbers of intervention and usual care patients per prac-
tice. Random number tables were used by and independ-
Table 1: Inclusion and exclusion criteria
Inclusion: • Age 75 years and over and listed as general practice patient
• Living at home
• Frail: Self reported Health score in the worst quartile of at least two of six COOP-WONCA charts (scoring range: 1, 
excellent, to 5 very bad): Overall health ≥4; Physical fitness ≥5; Changes in health ≥4; Daily activities ≥4; Mental health ≥3; 
Social activities ≥3
Exclusion: • Terminally ill as determined by PCPs
• Persons with dementia symptoms according to MMSE or 7-minute screen
• Living in residential homes.
• Participating in other research projects
Table 2: First Pilot: Selecting frail patients
Background: Measuring frailty is subject to debate and various operational definitions were proposed [15]. For our purpose we sought a 
valid easy administrable self-report instrument.
Objective: To determine the feasibility of multidimensional frailty screening instruments that could be sent by mail.
Methods: After a literature search three multidimensional screening instruments were selected and tested in one general practice 
among all 75+ patients: 1) VES-13, 2) Strawbridge's frailty screen, and 3) COOP-WONCA charts. Feasibility was expressed 
in percentage complete item response [20–22]. Our goal was to identify the worst quarter. This point of departure was 
based on studies by Fried and Rockwood who reported between 20–30% of 75+ people to be frail according to their 
measures [14,17].
Results: Of 116 patients 85 (81%) agreed to participate and 69 actually returned the questionnaire. The complete item response on 
the COOP-WONCA, Strawbridge screen, and VES-13 were 87%, 60% and 56% respectively. In order to identify a quarter of 
persons with the worst health on the COOP-WONCA, all persons were selected who scored in the worst quartile of at 
least two of the six charts (overall health ≥4; physical fitness ≥5; changes in health ≥4; daily activities ≥4; Feelings ≥3; social 
activities ≥3). This resulted in 23 persons who were further assessed at home by the RAI-HC. 90% had at least one chronic 
disease, two thirds had at least one ADL limitation, 60% had depressive symptoms (CESD>16) and 30% had cognitive 
impairment (MMSE<24) [37].
Conclusion: The COOP-WONCA was the most feasible screener. Our selection rule identified a frail group. The geriatric assessment 
identified new potentially treatable problems.
COOP-WONCA = COOP functional health assessment charts – World Organization of Family Doctors
VES-13 = Vulnerable Elders Survey-13
RAI-HC = Resident Assessment Instrument – Home Care version
MMSE = Mini Mental Screen ExaminationPage 3 of 9
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the VU medical center approved the study.
Study population main study
The PCPs provided the names and addresses of all their
listed patients of 75 years or older and living at home. All
persons received a health survey including the COOP-
WONCA charts in order to identify the 20–25% elderly
with the frailest functional health. The cut-offs per chart
were based on a combination of reference data and our
pilot data [22]. Inclusion and exclusion criteria are sum-
marized in Table 1.
Intervention(s)
The scores of all persons who filled out the health survey
and positively responded to the care offer were analyzed.
The intervention consisted of 7 elements; (1) All frail per-
sons and randomized to the intervention were contacted
by one of eight trained nurses. In the first visit the nurses
assess the health status and care needs by the Resident
Assessment Inventory Home Care version (RAI-HC), a
structured and computerized multidimensional geriatric
instrument that enables direct and validated identifica-
tion of problem areas [23,24]. The RAI-HC holds about
120 items and 30 domains of health and service needs
(Table 5). It takes between 45 to 60 minutes to complete;
(2) In our intervention the list of problems is discussed
with the patient to determine whether additional care is
needed.
Therefore the nurse and the patient make a hierarchy of
the problems; (3) The nurses design and execute individ-
ual suited care-plans that comply with patient priorities;
(4) The nurses are case-managers and offer to visit the
patients at least 5 times in a year in order to execute and
monitor the care-plan, to evaluate whether the care-needs
have changed and adapt the care/plan when needed; (5)
The nurses also meet the PCPs on a regular basis to discus
the care plans and to assure that medical actions are car-
ried out by the PCPs; (6) To assure the quality of care, the
nurses receive regularly educational updates and organize
monthly meetings to discuss problematic cases. Two staff
members supervise them. A national Dutch guideline on
home care nursing of frail elderly patients was available
[25]. This guideline was used to protocolize nurse inter-
ventions whenever possible; (7) The care plan is left at the
patients' house to enable other visiting health profession-
als to take notice of and report on the care plan.
Outcomes and measurements
Table 4 provides an overview of all outcomes and meas-
urements in the study.
Outcomes are:
1. Health related quality of life as measured with the Short
Form 36 (SF-36), and Quality Adjusted Life Years by
health utilities based on Euroqol (EQ-5D) [26,27];
3. (Days until) institutionalization: Hospital stay, place-
ment in nursing home or home for the elderly are sur-
veyed and crosschecked at institutes;
4. (Days until) mortality as checked with the PCPs;
5. Direct costs as measured by patient questionnaires with
three-monthly recall periods. These self-report data are
supplemented by data from the centralized regional phar-
macy database (medication use), regional hospital check,
and nursing home checks. In case patients are not able to
fill out the forms themselves a close relative will be
approached (Table 4).
Sample size calculation
For an anticipated Health related Quality of Life benefit
on at least two SF-36 domains with minimal relevant
Table 3: Second Pilot : Exploring the potential for quality of care improvement of preventive home visits among elderly persons.
Objective: To identify the need and possible benefit of home visits for frail patients, PCPs and nurses.
Method: The setting was a health center of 5400 patients with 3 PCPs and a practice nurse. Possible frailty was determined by the 
PCPs among their 75+ patients in the following cases: beginning dementia, active carcinoma, two or more medications for 
organ indication, treatments by two or more medical specialists, being 85+ and not contacted the PCP over the last three 
years, uncertainty regarding the ability to manage oneself, and all other persons the PCP felt it necessary to pay attention to. 
The nurses visited the patients and used an elaborate geriatric assessment protocol to identify psychosocial and medical 
problems. The nurses and the PCPs designed a care plan. The experiences of all participants were gathered by semi-
structured interviews.
Results: The participants (PCPs, nurses, patients) evaluated this approach positively. The PCPs gained better insight in medical and 
care situation of their elderly patients and experienced less work pressure. The nurses experienced better quality of care. 
The patients felt safer and more independent. The PCP also selected a number of healthy persons.
Conclusion: Home visits by nurses were regarded by all to have potential for quality of care improvement. Point of concern was the 
inadequate selection of frail patients by the PCPs. Also, the assessment protocol used by the nurses provided no triggers on 
when actions should follow.
PCP = Primary Care PhysicianPage 4 of 9
(page number not for citation purposes)
BMC Geriatrics 2005, 5:11 http://www.biomedcentral.com/1471-2318/5/11effect size Cohen's D = 0.5, 64 persons per group are
required with a two sided alpha of 0.05 and 80% proba-
bility. Anticipating on an annual attrition of 20% (mortal-
ity, inability to respond, unwilling) 75 persons per group
will be needed.
In a trial of 650 persons a reduction of 10% in hospital
admission, institutionalization and mortality can be
detected with a two-sided alpha of 0.05 and 80% proba-
bility (320 persons needed per group). Effect estimates are
based on previous meta-analyses [11,12].
Data-analysis
According to the 'intention-to-treat' principle differences
between intervention and usual care patients on mortal-
ity, hospitalization and nursing home placement (dichot-
omous outcomes) are tested by both chi-square tests and
logistic regression analysis. Differences in time until these
events will be analyzed with Cox-proportional hazard
modeling. For quality of life (continuous outcome: SF-36,
EQ-5D) General Linear Models (GLM), a technique for
repeated measures is used to analyze group differences.
Possible baseline differences in the outcome measures
will be accounted for in GLM. Additional subgroup-anal-
yses will be performed on types of recommendations in
the care-plans.
Potential confounding and effect-modification is checked
for sociodemographic characteristics, number and type of
chronic disease, (I)ADL functioning (GARS), cognitive
decline (IQCODE), mood (CES-D), behavioral problems
(incontinence, sleep, agitation en aggression), medication
use (centralized pharmacy data base) (Table 4) [28-30].
Quality of the data was assured by independent double
checks of all forms. Also our institute employs a quality
assurance policy. In this respect guidelines on all aspects
of research were issued and all projects are subject to
audits.
Economic evaluation
The economic evaluation will be performed alongside the
randomized trial from a societal perspective. Data on
resource use are collected in several ways: self report ques-
Table 4: Measurement scheme
Health screener Instrument T-1 T0 T1 T2
6 months 18 months
Functional Health status COOP-WONCA X X X
ADL & IADL GARS X X X
Cognitive decline IQCODE self report X
Depressive symptoms CES-D X X X
Chronic diseases Chronic diseases list X X
Mobility and Falls Questionnaire X X X
Body Mass Index Questionnaire X
Weight change Questionnaire X
Demographics Questionnaire X
Behavioral problems Questionnaire X
Incontinence Questionnaire X X X
Main Outcomes
a. Health related Quality of life SF36 + EQ5D X X X
b. Hospital admissions Patient + hospital database X X X
c. (Days until) Institutionalization PCP + nursing homes X
d. (Days until) Mortality Relatives + PCP X
e. Health resource utilization Self report + PCP + hospital + pharmacy databases X X X
PCP = Primary Care Physician
GARS = Groningen Activity Restriction Scale
CES-D = Center for Epidemiological Studies – Depression Scale
IQCODE = Informant Questionnaire on Cognitive Decline in the Elderly
SF36 = Short Form 36 item version
EQ5D = EuroQuality of life
X = measurement
T-1 = pre randomization health screening
T0 = Measurement immediately after randomization
T1, T2 = Follow-up measurementsPage 5 of 9
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community pharmacy records. Only direct healthcare
costs will be considered such as costs of consultations of
the general practitioner, nursing home physician, medical
specialist, hospitalizations, and medical department of
the nursing home, and use of medication and medical
aids. Medication data are retrieved from the centralized
pharmacy files in the research region. If available, Dutch
guideline prices are used to value resource use [31,32].
Otherwise, tariffs are used. Medication costs are valued
using prices of the Royal Dutch Society for Pharmacy [33].
Contacts with GPs and referrals will be checked as well in
GPs' patient information files.
Cost analysis
To compare costs between the two groups, confidence
intervals for the differences in mean costs are calculated
using bias-corrected and accelerated bootstrapping with
5000 replications. [34] For the cost-effectiveness analysis
the difference in total costs between the intervention and
usual care group are compared with the difference over 18
months in improvement of quality of life, reduced institu-
tionalization, hospitalization and mortality. In addition,
a cost-utility analysis will be done to assess the incremen-
tal costs per Quality Adjusted Life Years (QALY). Uncer-
tainty around the cost-effectiveness and cost-utility ratios
is calculated using the bias-corrected percentile method
(5000 replications) and presented in a cost-effectiveness
plane [35].
Patient outcome analysis
QALYs are calculated by multiplying the utility based on
EQ-5D scores with the amount of time a patient spent in
this particular health state [36]. Transitions between
health states are linearly interpolated.
Recruitment
The recruitment phase yielded a total of 33 PCP practices
that were willing to participate. Inclusion started in spring
2003 and lasted until summer 2004. Figure 1 provides an
overview of the recruitment and randomization. The
health questionnaire was mailed to 4823 patients. Of the
2949 (61%) responders, 658 frail patients were detected
and randomized.
Table 5: Case example of assessment by a nurse with the RAI-HC: triggered health risks
Client Assessed Problem Observed Action undertaken earlier? Relevant action now? Immediate action? Action later?
1. ADL / Revalidation potential X X
2. IADL / more formal care
3. Health promotion
4. Risk intramural admission
5. Communication impairment
6. Visual impairment
7. Alcohol abuse
8. Cognition
9. Behavior
10. Depression and Anxiety
11. Abuse
12. Social functioning
13. Heart and lungs X X
14. Dehydration X X
15. Falls
16. Nutrition
17. Dental health
18. Pain
19. Bedsores X X
20. Skin and food problems X X
21. Compliance
22. Vulnerable support system X
23. Medication management
24. Palliative care
25. Preventive health X X
26. Psychofarmaca use X X
27. Reduced service package
28. Environment
29. Feces incontinence
30. Urinal incontinence catheter XPage 6 of 9
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Females more often non-responded (41.3% versus
35.8%, X2 = 13.4 p < 0.001), as did slightly older persons
(83.5 versus 81.7 t = 13.8 p < 0.001).
Intervention
Eight nurses were trained in the use of the RAI-HC on lap-
tops. The nurses were relatively unskilled in computer use
so specific training was provided. Table 5 shows an exam-
ple of a patient's problems list. Based on the detected
problems the nurses design care plans.
Discussion
In this paper we describe the design of a randomized cost-
effectiveness trial of effect of preventive home visits by
nurses to frail elderly primary care patients as well as the
results of two pilot studies to determine the need and the
feasibility instruments to select the frailest portion among
elderly. The main study main study holds unique ele-
ments. The intervention concerns pro-active care that
should guarantee timely detection of patients with frailer
health, followed by structured nurse-led care focusing on
patients. It focuses on the client as well as on the system
around the client. The nurses use the Resident Assessment
Instrument; a comprehensive geriatric assessment proto-
Flow chart PIKOigure 1
Flow chart PIKO.
Postal health survey and 
informed consent to patients 
75+ years, living at home from 
33PCP practices
N=4823
Returned health survey 
N=2949 (61%)
N=1874 Unwilling / Unable 
-No informed consent (389) 
-Institutionalization (128) 
-Participates in other research (25)
-Ambulatory Mental health (31) 
-Special home care (13)
-Deceased (137) 
-Other (210)
-Unknown (941)
Eligible
N=658
Intervention
N=334
N=2291, Non-Eligibility:
-no informed consent (66) 
-not frail (2171) 
-dementia symptoms (54) 
Usual care 
N=324Page 7 of 9
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hereby, guides care planning.
The main study achieved a substantial response on the
postal COOP-WONCA screening. In our pilot study,
home visits by nurses were regarded to have potential for
quality of care improvement. Point of concern was the
inadequate selection of frail patients by the PCPs. Also,
the assessment protocol used by the nurses provided no
triggers on when actions should follow. In a second pilot
study, the COOP-WONCA emerged as the most feasible
postal screener compared to vulnerable elders survey
(VES-13) and the Frailty screening list of Strawbridge. Our
selection rule identified a frail group.
Limitations to the generalizability of our future findings
are firstly the non-response to the mailed health survey. A
number of persons (n = 100) responded but did not want
to participate because of their good health. We remain
uncertain about other non-responders being frailer and
perhaps in greater need of nurse support. In future
projects alternative means for health screening may be
tested in older PCP patients such as contacting consulting
patients. Secondly, our RAI assessment demanded a struc-
tured approach of computer skilled persons. The compu-
ter skills of the nurses were rather limited which led to
extensive additional training. Some nurses had difficulties
with the computerized assessments and disliked the struc-
tured format in which the assessment took place. Thirdly,
we remain uncertain about the best frailty measure to
identify persons that can benefit most from preventive
actions. We selected the COOP-WONCA because of its
broad health definition and very good feasibility. Last,
whether PCPs remain blind for group assignment during
he follow up remains to be seen. It is possible that the reg-
ular contacts with the nurses will reveal some of the
assignments.
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